Hevolution Foundation supports a wide range of scientific areas in aging biology and geroscience. We will fund research across the spectrum of the R&D value chain from basic aging biology, through geroscience, and clinical trials. However, precedence will be given to applications that have the potential of leading to new drugs and interventions that will delay the aging process, leading to prevention of age-related disorders, conditions, or age-related disorders and conditions, and loss of intrinsic capacities, including dependency.
In our pursuit of that goal, we will publicize funding opportunities through our website, which is set to cover the entire value chain of geroscience research, including: basic biology of aging, geroscience, clinical research and clinical trials. In addition, we intend to promote the development of new talent in the field by funding young researchers at multiple levels in their career; we will also lend support to science dissemination through conferences, and will support studies aimed at understanding the legal and regulatory aspects of aging and geroscience research.